The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
reported to the Securities and Exchange Commission (SEC)
by insider Bradbury Daniel since year 2005.
The trader's CIK number is 1236397.
At the time of this reporting, Bradbury Daniel is the Director of Illumina Inc .
(stock ticker symbol ILMN).
See this page for all insider trading activities at Illumina Inc .
Note that in the past BRADBURY DANIEL also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Bradbury Daniel since 2005.
Trade Date
Symbol
Company Name (Issuer)
Trade Type
Shares
Price ($)
Value ($)
2008-06-18
ILMN
Illumina Inc
Option Exercise
3,000
8.07
24,210
2008-06-18
ILMN
Illumina Inc
Sale
3,000
81.67
245,019
2007-11-16
AMLN
Amylin Pharmaceuticals Inc
Option Exercise
9,445
14.28
134,884
2007-05-07
AMLN
Amylin Pharmaceuticals Inc
Sale
2,894
41.90
121,258
2007-04-09
AMLN
Amylin Pharmaceuticals Inc
Sale
2,500
38.66
96,657
2007-03-22
AMLN
Amylin Pharmaceuticals Inc
Option Exercise
39,269
10.49
411,905
2007-03-07
AMLN
Amylin Pharmaceuticals Inc
Sale
2,500
37.00
92,500
2007-02-07
AMLN
Amylin Pharmaceuticals Inc
Sale
3,500
40.52
141,820
2007-01-09
AMLN
Amylin Pharmaceuticals Inc
Sale
2,500
38.51
96,276
2006-12-07
AMLN
Amylin Pharmaceuticals Inc
Sale
2,500
39.35
98,369
2006-11-07
AMLN
Amylin Pharmaceuticals Inc
Sale
3,000
44.51
133,536
2006-10-06
AMLN
Amylin Pharmaceuticals Inc
Sale
3,000
42.50
127,500
2006-09-08
AMLN
Amylin Pharmaceuticals Inc
Sale
2,111
44.25
93,411
2006-09-08
AMLN
Amylin Pharmaceuticals Inc
Sale
2,111
44.25
93,411
2006-08-07
AMLN
Amylin Pharmaceuticals Inc
Sale
3,000
47.41
142,230
2006-07-10
AMLN
Amylin Pharmaceuticals Inc
Sale
3,500
49.88
174,589
2006-06-07
AMLN
Amylin Pharmaceuticals Inc
Sale
3,000
44.92
134,775
2006-05-05
AMLN
Amylin Pharmaceuticals Inc
Sale
3,000
43.30
129,899
2006-04-07
AMLN
Amylin Pharmaceuticals Inc
Sale
3,000
46.10
138,300
2006-03-07
AMLN
Amylin Pharmaceuticals Inc
Sale
2,000
42.50
85,000
2006-03-07
AMLN
Amylin Pharmaceuticals Inc
Sale
2,000
42.50
85,000
2006-02-23
AMLN
Amylin Pharmaceuticals Inc
Option Exercise
12,552
.78
9,803
2006-02-23
AMLN
Amylin Pharmaceuticals Inc
Sale
12,552
41.00
514,632
2006-02-21
AMLN
Amylin Pharmaceuticals Inc
Option Exercise
12,551
.78
9,802
2006-02-21
AMLN
Amylin Pharmaceuticals Inc
Sale
12,551
39.65
497,647
2006-02-16
AMLN
Amylin Pharmaceuticals Inc
Option Exercise
12,551
.78
9,802
2006-02-16
AMLN
Amylin Pharmaceuticals Inc
Sale
12,551
38.25
480,075
2006-02-07
AMLN
Amylin Pharmaceuticals Inc
Sale
2,000
38.00
76,000
2006-01-09
AMLN
Amylin Pharmaceuticals Inc
Sale
2,000
43.00
86,000
2006-01-05
AMLN
Amylin Pharmaceuticals Inc
Option Exercise
12,972
4.94
64,055
2005-12-07
AMLN
Amylin Pharmaceuticals Inc
Sale
2,000
37.20
74,402
2005-11-07
AMLN
Amylin Pharmaceuticals Inc
Sale
2,000
34.75
69,500
2005-10-07
AMLN
Amylin Pharmaceuticals Inc
Sale
2,000
34.75
69,500
2005-09-08
AMLN
Amylin Pharmaceuticals Inc
Sale
2,000
31.75
63,500
2005-08-05
AMLN
Amylin Pharmaceuticals Inc
Sale
2,000
20.01
40,020
2005-07-07
AMLN
Amylin Pharmaceuticals Inc
Sale
1,500
20.50
30,750
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Bradbury Daniel
(Director of Illumina Inc at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.
